Trivium Point Advisory LLC Trims Position in American Healthcare REIT, Inc. $AHR

Trivium Point Advisory LLC cut its position in American Healthcare REIT, Inc. (NYSE:AHR) by 21.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,820 shares of the company’s stock after selling 5,833 shares during the period. Trivium Point Advisory LLC’s holdings in American Healthcare REIT were worth $765,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. GAMMA Investing LLC increased its stake in shares of American Healthcare REIT by 22.1% in the second quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock worth $63,000 after purchasing an additional 311 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of American Healthcare REIT by 1.4% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 29,300 shares of the company’s stock worth $1,086,000 after purchasing an additional 393 shares in the last quarter. Benjamin Edwards Inc. grew its stake in American Healthcare REIT by 3.2% during the first quarter. Benjamin Edwards Inc. now owns 14,368 shares of the company’s stock valued at $435,000 after acquiring an additional 444 shares in the last quarter. Xponance Inc. grew its stake in American Healthcare REIT by 4.3% during the first quarter. Xponance Inc. now owns 11,489 shares of the company’s stock valued at $348,000 after acquiring an additional 470 shares in the last quarter. Finally, Nissay Asset Management Corp Japan ADV grew its stake in American Healthcare REIT by 2.5% during the first quarter. Nissay Asset Management Corp Japan ADV now owns 22,663 shares of the company’s stock valued at $687,000 after acquiring an additional 543 shares in the last quarter. 16.68% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on AHR shares. Robert W. Baird started coverage on shares of American Healthcare REIT in a research note on Friday, July 18th. They set an “outperform” rating and a $41.00 target price for the company. Truist Financial raised their target price on shares of American Healthcare REIT from $44.00 to $46.00 and gave the company a “buy” rating in a research note on Tuesday, August 26th. Morgan Stanley reaffirmed an “overweight” rating on shares of American Healthcare REIT in a research note on Wednesday, September 3rd. Royal Bank Of Canada raised their target price on shares of American Healthcare REIT from $39.00 to $45.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Finally, KeyCorp raised their target price on shares of American Healthcare REIT from $34.00 to $40.00 and gave the company an “overweight” rating in a research note on Wednesday, June 11th. One equities research analyst has rated the stock with a Strong Buy rating and ten have given a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $44.11.

American Healthcare REIT Stock Performance

Shares of NYSE:AHR opened at $42.04 on Wednesday. American Healthcare REIT, Inc. has a 52 week low of $23.66 and a 52 week high of $43.52. The stock has a market capitalization of $7.09 billion, a P/E ratio of -191.09, a PEG ratio of 2.15 and a beta of 1.09. The firm has a fifty day simple moving average of $41.22 and a two-hundred day simple moving average of $36.11. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.41.

American Healthcare REIT (NYSE:AHR) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The business had revenue of $542.50 million during the quarter, compared to analysts’ expectations of $539.49 million. During the same period last year, the company posted $0.33 EPS. The business’s revenue was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. On average, analysts expect that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.

American Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio (DPR) is -454.55%.

Insider Activity

In other news, EVP Mark E. Foster sold 3,850 shares of the firm’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the sale, the executive vice president owned 59,100 shares in the company, valued at approximately $2,475,699. This trade represents a 6.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.00% of the company’s stock.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.